Esteves-Jaramillo A, Herbas RIMJ, López-Collada VR

Language: Spanish
References: 17
Page: 192-196
PDF size: 173.80 Kb.

ABSTRACT

No abstract

REFERENCES

1. Cochi SL, Linkins RW. The final phase of polio eradication: new vaccines and complex choices. J Infect Dis 2012;205(2):169-71.

2. Henderson DA, Witte JJ, Morris L, Langmuir AD. Paralytic Disease Associated with Oral Polio Vaccines. JAMA 1964;190:41-8.

3. Schonberger LB, McGowan JE, Jr., Gregg MB. Vaccineassociated poliomyelitis in the United States, 1961-1972. Am J Epidemiol 1976;104(2):202-11.

4. Sutter RW, Brink EW, Cochi SL, et al. A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am J Public Health 1989;79(4):495-8.

5. Vacunacion CNd. Eventos Temporalmente Asociados a la Vacunacion. Manual de Procedimientos Tecnicos. In: Infancia PdA, ed. Mexico, D.F.: Secretaria de Salud; 2002.

6. Stolley PD, Joseph JM, Allen JC, Deane G, Janney JH. Poliomyelitis associated with type-2 poliovirus vaccine strain. Possible transmission from an immunised child to a nonimmunised child. Lancet 1968;1(7544):661-3.

7. Albrecht RM. Poliomyelitis from a vaccinee. Lancet 1968;1(7556):1371.

8. The relation between acute persisting spinal paralysis and poliomyelitis vaccine (oral): results of a WHO enquiry. Bull World Health Organ 1976;53(4):319-31.

9. The relation between acute persisting spinal paralysis and poliomyelitis vaccine--results of a ten-year enquiry. WHO Consultative Group. Bull World Health Organ 1982;60(2):231-42.

10. Esteves K. Safety of oral poliomyelitis vaccine: results of a WHO enquiry. Bull World Health Organ 1988;66(6):739-46.

11. Aylward RB, Cochi SL. Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission. Bull World Health Organ 2004;82(1):40-6.

12. 12. Strebel PM, Sutter RW, Cochi SL, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 1992;14(2):568-79.

13. 13. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997;46(RR- 3):1-25.

14. Wattigney WA, Mootrey GT, Braun MM, Chen RT. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Pediatrics 2001;107(5):E83.

15. Recommendations of the Advisory Committee on Immunization Practices: revised recommendations for routine poliomyelitis vaccination. MMWR Morb Mortal Wkly Rep 1999;48(27):590.

16. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination. MMWR Morb Mortal Wkly Rep 2009;58(30):829-30.

17. Andrus JK, Strebel PM, de Quadros CA, Olive JM. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91. Bull World Health Organ 1995;73(1):33-40.